Research Archive — Page 4 of 136

June 15, 2026

Study identifies genetic cause for rare skin condition, points to new therapeutic option

The research highlights the value of studying rare genetic diseases to uncover fundamental immunological mechanisms.

June 12, 2026

Second Vanderbilt Health team wins NIH Replication Prize

Led by Simon Vandekar, PhD, a group of biostatisticians earned the honor for tools that help brain researchers tell strong, trustworthy findings from weak ones. Vanderbilt Health teams took two of 15 total NIH prizes.

June 9, 2026

Study: Lung biopsy cryoprobe increases diagnostic yield over standard forceps

The FROSTBITE-2 trial used the 1.1-millimeter cryoprobe which, unlike the larger probes, is small enough to remove the biopsy specimen through the working channel without having to remove the scope, which increases safety.

June 5, 2026

Research addresses barriers to success for antibody-based therapies for solid head, neck and pancreatic tumors

A new platform allows visualization of drug-tumor interactions in human solid tumors, providing a tool for measuring drug delivery and signaling.

June 5, 2026

New research: Heart drug may also limit the spread of cancer

For the past 20 years, Vanderbilt Health researchers have been studying ifetroban for its potential to treat conditions ranging from fibrotic lung disease to heart failure in patients with Duchenne muscular dystrophy.

June 3, 2026

Study finds link between neighborhood opportunity and mental health-related hospitalizations in youths

Opportunity is measured by the Child Opportunity Index 3.0, a publicly available, multidimensional metric that captures neighborhood conditions that influence children’s health, like education, housing, access to healthy food, environment and societal factors.